AGTC Genomics

AGTC Genomics AGTC Genomics delivers advanced, affordable genomic solutions.

AGTC Genomics is a leading precision medicine company based in Malaysia, dedicated to advancing healthcare through cutting-edge genomic technologies. With state-of-the-art facilities and internationally accredited laboratories, the company offers high-quality genomic testing and analysis for clinical and research applications. AGTC plays a key role in making precision diagnostics more accessible and affordable across Southeast Asia. Its mission is to empower clinicians and researchers with accurate, fast, and actionable genetic insights to improve patient outcomes.

๐€๐†๐“๐‚ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ ๐‚๐จ๐ง๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ž๐ฌ ๐ญ๐จ ๐Œ๐š๐ฅ๐š๐ฒ๐ฌ๐ข๐šโ€™๐ฌ ๐๐ซ๐ž๐œ๐ข๐ฌ๐ข๐จ๐ง ๐Œ๐ž๐๐ข๐œ๐ข๐ง๐ž ๐‘๐จ๐š๐๐ฆ๐š๐ฉAGTC Genomics is honoured to be invited to contribute ...
03/11/2025

๐€๐†๐“๐‚ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ ๐‚๐จ๐ง๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ž๐ฌ ๐ญ๐จ ๐Œ๐š๐ฅ๐š๐ฒ๐ฌ๐ข๐šโ€™๐ฌ ๐๐ซ๐ž๐œ๐ข๐ฌ๐ข๐จ๐ง ๐Œ๐ž๐๐ข๐œ๐ข๐ง๐ž ๐‘๐จ๐š๐๐ฆ๐š๐ฉ

AGTC Genomics is honoured to be invited to contribute to the development of the Precision Medicine Malaysia Roadmap, a national initiative to chart the future of precision medicine in Malaysia, organized by the Institute For Medical Research (IMR) and National Institute of Health (NIH).

As a leader in genomics technology, AGTC Genomics is proud to power precision medicine research and clinical practice alongside our industry peers โ€” Premier Integrated Labs, Oncode Scientific Sdn Bhd, Precision Diagnostics, Neoscience Sdn Bhd, and Supagene.Asia โ€” in the recent multi-stakeholder workshop aimed at shaping Malaysiaโ€™s precision medicine ecosystem.

This Ministry of Science, Technology and Innovation (MOSTI), Ministry of Higher Education (MoHE), and Ministry of Health (MoH) collaborative engagement brought together key stakeholders across research, clinical, and industry sectors to align efforts in advancing personalized healthcare solutions. The roadmap emphasizes the critical role of genomics, bioinformatics, and pharmacogenetics in driving more effective, data-driven, and equitable healthcare for the Malaysian population.

At AGTC Genomics, we remain committed to empowering the next generation of healthcare innovation through advanced sequencing technologies, talent development, and translational research partnerships โ€” moving precision medicine from vision to reality.

โœจ Happy Deepavali from AGTC Genomics! โœจWishing our colleagues, partners, clients and friends a joyful Festival of Lights...
20/10/2025

โœจ Happy Deepavali from AGTC Genomics! โœจ

Wishing our colleagues, partners, clients and friends a joyful Festival of Lights filled with happiness, health, and new beginnings. May this season bring light to every path and success to every journey.

Happy Deepavali! ๐Ÿช”

18/10/2025

๐€๐†๐“๐‚ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ ๐๐š๐ซ๐ญ๐ข๐œ๐ข๐ฉ๐š๐ญ๐ž๐ ๐ข๐ง ๐๐ข๐จ๐—๐‚๐ž๐ž๐ ๐๐š๐ง๐ž๐ฅ ๐š๐ญ ๐๐ˆ๐‚๐„ 2025 ๐จ๐ง ๐๐ข๐จ-๐๐š๐ฌ๐ž๐ ๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง

AGTC Genomics was honoured to participate as a panel speaker at NICE 2025 โ€“ BioXCeed, held at the World Trade Centre Kuala Lumpur (WTCKL) on 9 October 2025. The panel discussion, titled โ€œDeveloping Bio-Based Entities: The Challenges and How to Overcome Them,โ€ brought together leaders from biotechnology, academia, and industry to address the future of bio-based innovation in Malaysia and beyond.

Representing AGTC Genomics, Prof. Dr. Chee-Onn Leong, Founder & CEO, shared insights on the role of genomics and precision biotechnology in accelerating the development of sustainable bio-based solutions. He highlighted key challenges such as regulatory readiness, validation frameworks, commercial scalability, and market adoption, while emphasising the importance of public-private partnerships, translational research, and regional collaboration.

During the session, AGTC Genomics reaffirmed its commitment to advancing Malaysiaโ€™s bioeconomy through genomic intelligence, multi-omics platforms, and deep-tech innovation. As Malaysiaโ€™s leading genomics center, the lab continues to drive innovation toward real-world applications in healthcare, agriculture, environmental science, and industrial biology.

The BioXCeed panel was part of the broader NICE 2025: Innovation, Growth, Global Impact initiative, which serves as a national platform to strengthen Malaysiaโ€™s position as a biotechnology and innovation hub in Southeast Asia.

AGTC Genomics extends its appreciation to the organisers, collaborators, and participants who contributed to this impactful discussion. We look forward to continuing meaningful engagements that advance precision medicine, biotechnology, and innovation ecosystems in the region.

Ministry of Science, Technology and Innovation

Bioeconomy Corporation

MRANTI

Malaysian Technology Development Corporation (MTDC)

๐ƒ๐ซ๐ข๐ฏ๐ข๐ง๐  ๐๐ซ๐ž๐œ๐ข๐ฌ๐ข๐จ๐ง ๐ข๐ง ๐‚๐š๐ง๐œ๐ž๐ซ ๐‚๐š๐ซ๐ž: ๐€๐†๐“๐‚ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ ๐’๐ก๐จ๐ฐ๐œ๐š๐ฌ๐ž๐ฌ ๐‚๐†๐ ๐’๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ฌ ๐š๐ญ ๐‡๐จ๐ฌ๐ฉ๐ข๐ญ๐š๐ฅ ๐’๐ฎ๐ฅ๐ญ๐š๐ง๐š๐ก ๐๐š๐ก๐ข๐ฒ๐š๐ก ๐‚๐Œ๐„ ๐“๐š๐ฅ๐ค.Excited to...
17/10/2025

๐ƒ๐ซ๐ข๐ฏ๐ข๐ง๐  ๐๐ซ๐ž๐œ๐ข๐ฌ๐ข๐จ๐ง ๐ข๐ง ๐‚๐š๐ง๐œ๐ž๐ซ ๐‚๐š๐ซ๐ž: ๐€๐†๐“๐‚ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ ๐’๐ก๐จ๐ฐ๐œ๐š๐ฌ๐ž๐ฌ ๐‚๐†๐ ๐’๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ฌ ๐š๐ญ ๐‡๐จ๐ฌ๐ฉ๐ข๐ญ๐š๐ฅ ๐’๐ฎ๐ฅ๐ญ๐š๐ง๐š๐ก ๐๐š๐ก๐ข๐ฒ๐š๐ก ๐‚๐Œ๐„ ๐“๐š๐ฅ๐ค.

Excited to share the CME Talk held at Hospital Sultanah Bahiyah on October 14th, where AGTC Genomics hosted an insightful session on โ€œIntegration of Comprehensive Genomic Profiling (CGP) into the Cancer Care Journey to Enhance Patient Outcomesโ€. Dr. Boon Shing Tan our Chief Technology Officer, explored how comprehensive genomic solutions are transforming the cancer care landscape.โ€‹

๐‘จ๐‘ฎ๐‘ป๐‘ช ๐‘ฎ๐’†๐’๐’๐’Ž๐’Š๐’„๐’”: ๐‘ฌ๐’Ž๐’‘๐’๐’˜๐’†๐’“๐’Š๐’๐’ˆ ๐‘ท๐’“๐’†๐’„๐’Š๐’”๐’Š๐’๐’ ๐‘ด๐’†๐’…๐’Š๐’„๐’Š๐’๐’†

AGTC Genomics leads the way in making advanced genomics accessible and affordable for all, enabling healthcare professionals and patients with personalized insights for improved outcomes. Our range of clinical genomic solutions leverages next-generation sequencing (NGS) technology and bioinformatics to offer high-throughput, accurate, and actionable data that brings precision medicine into routine cancer care.โ€‹

๐‘ฐ๐’๐’๐’๐’—๐’‚๐’•๐’Š๐’๐’ ๐’Š๐’ ๐‘ช๐’‚๐’๐’„๐’†๐’“ ๐‘ฎ๐’†๐’๐’๐’Ž๐’Š๐’„๐’”

Our cutting-edge cancer solutions include:

- Comprehensive Gene Profiling (CGP) platforms analyze hundreds of actionable mutations in tumor tissues, empowering oncologists with personalized treatment plans.โ€‹

- Liquid Biopsy non-invasive tests for early detection, metastatic disease monitoring, and cancer recurrenceโ€”allowing timely intervention and better outcomes.โ€‹

- Hereditary and Early Cancer Risk Screening help identify susceptibility in healthy individuals and those with a family history, ensuring proactive care.โ€‹

- Whole Genome/Exome Sequencing & Rare Disease Solutions accelerate diagnoses in undiagnosed and rare cases, making comprehensive genetics practical in clinical settings.โ€‹

๐–๐ก๐ฒ ๐‚๐ก๐จ๐จ๐ฌ๐ž ๐€๐†๐“๐‚ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ?

- Local Testing, Global Standards: State-of-the-art sequencing and analysis performed in Malaysia, with results in just 7-14 days.โ€‹

- Expert Team: Scientists, clinicians, and bioinformaticians offering world-class support and actionable genomic insights.โ€‹

At AGTC Genomics, we are passionate about transforming healthcare through personalized cancer diagnostics, enabling clinicians to make confident, evidence-based treatment decisions for every patient. Thank you to all who joined us at Hospital Sultanah Bahiyahโ€”letโ€™s continue driving innovation and precision in medicine!

๐€๐†๐“๐‚ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ ๐‹๐š๐ฎ๐ง๐œ๐ก๐ž๐ฌ ๐Œ๐š๐ฅ๐š๐ฒ๐ฌ๐ข๐šโ€™๐ฌ ๐…๐ข๐ซ๐ฌ๐ญ ๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ๐ฅ๐ฒ ๐•๐š๐ฅ๐ข๐๐š๐ญ๐ž๐ ๐Œ๐ฎ๐ฅ๐ญ๐ข-๐‚๐š๐ง๐œ๐ž๐ซ ๐„๐š๐ซ๐ฅ๐ฒ ๐ƒ๐ž๐ญ๐ž๐œ๐ญ๐ข๐จ๐ง ๐“๐ž๐ฌ๐ญ ๐š๐ญ ๐๐ˆ๐‚๐„ 2025 โ€” ๐‚๐š๐ฉ๐š๐›๐ฅ๐ž ๐จ๐Ÿ...
11/10/2025

๐€๐†๐“๐‚ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ ๐‹๐š๐ฎ๐ง๐œ๐ก๐ž๐ฌ ๐Œ๐š๐ฅ๐š๐ฒ๐ฌ๐ข๐šโ€™๐ฌ ๐…๐ข๐ซ๐ฌ๐ญ ๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ๐ฅ๐ฒ ๐•๐š๐ฅ๐ข๐๐š๐ญ๐ž๐ ๐Œ๐ฎ๐ฅ๐ญ๐ข-๐‚๐š๐ง๐œ๐ž๐ซ ๐„๐š๐ซ๐ฅ๐ฒ ๐ƒ๐ž๐ญ๐ž๐œ๐ญ๐ข๐จ๐ง ๐“๐ž๐ฌ๐ญ ๐š๐ญ ๐๐ˆ๐‚๐„ 2025 โ€” ๐‚๐š๐ฉ๐š๐›๐ฅ๐ž ๐จ๐Ÿ ๐ƒ๐ž๐ญ๐ž๐œ๐ญ๐ข๐ง๐  20 ๐Œ๐š๐ฃ๐จ๐ซ ๐“๐ฒ๐ฉ๐ž๐ฌ ๐š๐ง๐ 110 ๐’๐ฎ๐›๐ญ๐ฒ๐ฉ๐ž๐ฌ ๐จ๐Ÿ ๐‚๐š๐ง๐œ๐ž๐ซ๐ฌ ๐š๐ญ ๐„๐š๐ซ๐ฅ๐ฒ ๐’๐ญ๐š๐ ๐ž๐ฌ

Kuala Lumpur, 9 October 2025 โ€“ AGTC Genomics, Malaysiaโ€™s leading precision medicine and genomics company, proudly unveiled the nationโ€™s first clinically validated Multi-Cancer Early Detection (MCED) test during the NICE 2025 exhibition, marking a transformative milestone in Malaysiaโ€™s journey toward accessible, data-driven healthcare.

The newly launched MCED test harnesses deep-sequencing next-generation liquid biopsy technology, enabling the detection of 20 major cancer types and 110 subtypes at their earliest, most treatable stages โ€” all through a simple blood test. This innovation represents a paradigm shift in how cancers can be detected and managed, paving the way for earlier intervention, better survival outcomes, and reduced healthcare burden across the country.

โ€œThis launch is more than a technological breakthrough; it reflects Malaysiaโ€™s growing strength in precision medicine and genomics innovation. By detecting multiple cancers early, we are redefining how healthcare systems can respond to one of humanityโ€™s greatest challenges,โ€ said Prof. Dr. Chee-Onn Leong, Founder and Chief Executive Officer of AGTC Genomics.

The MCED test underscores AGTC Genomicsโ€™ commitment to advancing early detection, personalized healthcare, and population-wide cancer prevention strategies that align with Malaysiaโ€™s National Biotechnology Policy and Precision Medicine Roadmap.

AGTC Genomics extends its deepest appreciation to YB Chang Lih Kang, Minister of Science, Technology and Innovation (MOSTI), for gracing the launch event, and to Bioeconomy Corporation for their steadfast support in fostering Malaysiaโ€™s biotechnology ecosystem and driving innovation that bridges science, technology, and clinical application.

This milestone marks another step in AGTC Genomicsโ€™ mission to make precision medicine more accessible, affordable, and impactful for all Malaysians โ€” ensuring that the future of healthcare is not only advanced but also inclusive.

๐€๐›๐จ๐ฎ๐ญ ๐€๐†๐“๐‚ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ

AGTC Genomics is Malaysiaโ€™s leading precision medicine company, specializing in next-generation sequencing (NGS), multi-omics analysis, and liquid biopsy technologies for cancer, rare diseases, and personalized health. The company is the first in Malaysia to receive ISO 15189 accreditation for human whole-genome sequencing and continues to pioneer innovations that bring world-class genomics and clinical diagnostics closer to patients across Southeast Asia.

๐€๐†๐“๐‚ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ ๐‚๐„๐Ž ๐’๐ก๐š๐ซ๐ž๐ฌ ๐•๐ข๐ฌ๐ข๐จ๐ง๐š๐ซ๐ฒ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐จ๐ง ๐“๐ซ๐š๐ง๐ฌ๐ฅ๐š๐ญ๐ข๐ง๐  ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ ๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง ๐Ÿ๐ซ๐จ๐ฆ ๐‹๐š๐› ๐ญ๐จ ๐๐ž๐๐ฌ๐ข๐๐ž ๐š๐ญ ๐๐ข๐จ๐—๐‚๐ž๐ž๐ 2025Kuala...
11/10/2025

๐€๐†๐“๐‚ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ ๐‚๐„๐Ž ๐’๐ก๐š๐ซ๐ž๐ฌ ๐•๐ข๐ฌ๐ข๐จ๐ง๐š๐ซ๐ฒ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐จ๐ง ๐“๐ซ๐š๐ง๐ฌ๐ฅ๐š๐ญ๐ข๐ง๐  ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ ๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง ๐Ÿ๐ซ๐จ๐ฆ ๐‹๐š๐› ๐ญ๐จ ๐๐ž๐๐ฌ๐ข๐๐ž ๐š๐ญ ๐๐ข๐จ๐—๐‚๐ž๐ž๐ 2025

Kuala Lumpur, 9 October 2025 โ€“ AGTC Genomics, Malaysiaโ€™s leading precision medicine and genomics solutions provider, proudly participated in BioXCeed 2025, held at the World Trade Centre Kuala Lumpur. The event, organized in conjunction with NICE 2025 by the Ministry of Science, Technology and Innovation (MOSTI) and the Malaysian Technology Development Corporation (MTDC), brought together innovators and industry leaders driving the growth of Malaysiaโ€™s bioeconomy.

During the panel session titled โ€œDeveloping Bio-based Entities: The Challenges and How to Overcome Themโ€, Prof. Dr. Leong Chee Onn, Founder and Chief Executive Officer of AGTC Genomics, shared his expertise and leadership perspectives on the evolving genomics landscape in Southeast Asia.

Prof. Leong emphasized the critical need to bridge the gap between scientific discovery and clinical application, highlighting how emerging deep sequencing technologies and multi-omics innovations are transforming diagnostics, personalized healthcare, and biotechnology entrepreneurship across the region.

He also offered guidance to young entrepreneurs in deeptech and healthtech, underscoring the importance of translating technology from the research bench to real-world clinical impact. His insights focused on fostering a sustainable innovation ecosystem where industry, academia, and government collaborate to accelerate Malaysiaโ€™s leadership in precision medicine.

โ€œInnovation in life sciences must be driven not just by scientific curiosity, but by real-world impact. Translating genomics discoveries into clinical applications requires a strong ecosystem, visionary leadership, and collective commitment to improving human health,โ€ said Prof. Dr. Leong Chee Onn, CEO of AGTC Genomics.

AGTC Genomics extends its gratitude to YB Chang Lih Kang, MOSTI, and Bioeconomy Corporation for their continuous support in developing Malaysiaโ€™s biotechnology and precision medicine sector, and for providing platforms like BioXCeed that nurture innovation and entrepreneurship.

๐€๐›๐จ๐ฎ๐ญ ๐€๐†๐“๐‚ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ
AGTC Genomics is Malaysiaโ€™s leading precision medicine and genomics company, specializing in next-generation sequencing, liquid biopsy, pharmacogenomics, and multi-omics solutions for clinical and translational research. The companyโ€™s mission is to make advanced genomics and personalized healthcare accessible and affordable across Malaysia and the Southeast Asian region.

๐ƒ๐š๐ฒ 1 ๐š๐ญ ๐๐ˆ๐‚๐„ 2025 โ€“ ๐€ ๐…๐ซ๐ฎ๐ข๐ญ๐Ÿ๐ฎ๐ฅ ๐’๐ญ๐š๐ซ๐ญ ๐Ÿ๐จ๐ซ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ & ๐๐ซ๐ž๐œ๐ข๐ฌ๐ข๐จ๐ง ๐Œ๐ž๐๐ข๐œ๐ข๐ง๐žDay 1 of NICE 2025 has concluded with exciting mo...
07/10/2025

๐ƒ๐š๐ฒ 1 ๐š๐ญ ๐๐ˆ๐‚๐„ 2025 โ€“ ๐€ ๐…๐ซ๐ฎ๐ข๐ญ๐Ÿ๐ฎ๐ฅ ๐’๐ญ๐š๐ซ๐ญ ๐Ÿ๐จ๐ซ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ & ๐๐ซ๐ž๐œ๐ข๐ฌ๐ข๐จ๐ง ๐Œ๐ž๐๐ข๐œ๐ข๐ง๐ž

Day 1 of NICE 2025 has concluded with exciting momentum. From forging new R&D collaborations to signing business partnership contracts, we are excited to be extending our efforts in advancing genome research and precision medicine in Malaysia and beyond, across:

๐Ÿ”น Pharmacogenomics โ€“ ensuring safer and more effective therapies

๐Ÿ”น Cancer Diagnostics โ€“ advancing early detection and targeted treatment

๐Ÿ”น Nutrigenomics โ€“ enabling personalized health and nutrition strategies

๐Ÿ”น Drug Discovery & Development โ€“ accelerating translational research into new therapies

๐Ÿ”น Cell Therapies Research & Profiling โ€“ paving the way for next-generation regenerative medicine

A sincere thank you to Ministry of Science, Technology and Innovation (MOSTI) and Bioeconomy Corporation for the invitation and for establishing such an excellent platform that stimulates collaboration between industries, academia, and innovators.

๐Ÿ“ฃ ๐‚๐š๐ญ๐œ๐ก ๐ฎ๐ฌ ๐จ๐ง ๐“๐ก๐ฎ๐ซ๐ฌ๐๐š๐ฒ, 9 ๐Ž๐œ๐ญ๐จ๐›๐ž๐ซ 2025:

Weโ€™ll be catching up with our CEO, Prof. Dr. Chee-Onn Leong, during the panel discussion, and unveiling a new product launch. Donโ€™t miss itโ€”see you there!

๐Ÿš€ ๐„๐ฑ๐ฉ๐š๐ง๐๐ข๐ง๐  ๐Ž๐ฎ๐ซ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ ๐‚๐š๐ฉ๐š๐›๐ข๐ฅ๐ข๐ญ๐ข๐ž๐ฌ ๐ฐ๐ข๐ญ๐ก ๐ˆ๐ฅ๐ฅ๐ฎ๐ฆ๐ข๐ง๐š ๐Œ๐ข๐’๐ž๐ช ๐ข100AGTC Genomics is proud to announce the installation of the...
04/10/2025

๐Ÿš€ ๐„๐ฑ๐ฉ๐š๐ง๐๐ข๐ง๐  ๐Ž๐ฎ๐ซ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ ๐‚๐š๐ฉ๐š๐›๐ข๐ฅ๐ข๐ญ๐ข๐ž๐ฌ ๐ฐ๐ข๐ญ๐ก ๐ˆ๐ฅ๐ฅ๐ฎ๐ฆ๐ข๐ง๐š ๐Œ๐ข๐’๐ž๐ช ๐ข100

AGTC Genomics is proud to announce the installation of the Illumina MiSeq i100, the latest next-generation sequencing (NGS) platform built for speed, accuracy, and affordability.

โœจ Key Features

๐Ÿ”น Faster turnaround time โ€“ optimized workflows for rapid sequencing and clinical reporting

๐Ÿ”น Lower cost per sample โ€“ flexible throughput for more accessible testing

๐Ÿ”น High accuracy & reliability โ€“ proven Illumina sequencing chemistry

This unit will be used exclusively for Infectious Disease Surveillance and Research, supporting pathogen detection, monitoring, and public health initiatives with cutting-edge sequencing technology.

With this new platform, AGTC Genomics strengthens its mission to make precision medicine more accessible and affordable for patients, clinicians, and researchers across the region.

A heartfelt thank you to ScienceVision Sdn Bhd for the continuous support that has led to our success. We look forward to more fruitful collaboration and partnership in driving genomics innovation forward.

๐ŸŒŸ ๐Œ๐ž๐ž๐ญ ๐€๐†๐“๐‚ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ ๐š๐ญ ๐๐ˆ๐‚๐„ 2025! ๐ŸŒŸWe are excited to be part of the National Innovation and Commercialisation Expo (NIC...
03/10/2025

๐ŸŒŸ ๐Œ๐ž๐ž๐ญ ๐€๐†๐“๐‚ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ ๐š๐ญ ๐๐ˆ๐‚๐„ 2025! ๐ŸŒŸ

We are excited to be part of the National Innovation and Commercialisation Expo (NICE) 2025, from 6โ€“9 October 2025 at World Trade Centre Kuala Lumpur.

๐Ÿ“ Visit us at Booth A56 to discover how AGTC Genomics is building a regional hub for innovation with:

๐Ÿ”น Advanced genome research driving precision medicine and population health

๐Ÿ”น Breakthrough solutions in cancer diagnostics, infectious disease surveillance, and pharmacogenomics

๐Ÿ”น Cutting-edge microbiome and multi-omics technologies for health, agriculture, and sustainability

๐Ÿ”น Next-generation agrigenomics solutions to advance crop, aquaculture, and livestock improvement

๐Ÿ”น Integrated bioinformatics & AI analytics to unlock new biological insights

๐Ÿ”น A first look at new technologies launching in 2026 that will further transform diagnostics, research, and patient care

Join us at NICE 2025 and explore how genomics, agrigenomics, and AI-powered multi-omics can create a healthier, more sustainable future.

We look forward to meeting you at Booth A56!

Bioeconomy Corporation
Kementerian Sains, Teknologi dan Inovasi (MOSTI)

๐ŸŒ ๐€๐†๐“๐‚ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ ๐š๐ญ ๐๐ˆ๐‚๐„ 2025 โ€“ ๐’๐ก๐š๐ซ๐ข๐ง๐  ๐Œ๐š๐ฅ๐š๐ฒ๐ฌ๐ข๐šโ€™๐ฌ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ ๐’๐ฎ๐œ๐œ๐ž๐ฌ๐ฌ ๐’๐ญ๐จ๐ซ๐ฒWe are honored that Ministry of Science, Technol...
03/10/2025

๐ŸŒ ๐€๐†๐“๐‚ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ ๐š๐ญ ๐๐ˆ๐‚๐„ 2025 โ€“ ๐’๐ก๐š๐ซ๐ข๐ง๐  ๐Œ๐š๐ฅ๐š๐ฒ๐ฌ๐ข๐šโ€™๐ฌ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ ๐’๐ฎ๐œ๐œ๐ž๐ฌ๐ฌ ๐’๐ญ๐จ๐ซ๐ฒ

We are honored that Ministry of Science, Technology and Innovation (MOSTI) and Bioeconomy Corporation have invited AGTC Genomics to share our journey at NICE 2025 (National Innovation & Creative Economy Expo), Malaysiaโ€™s premier platform showcasing innovation, technology, and sustainability.

At the Panel Discussion on Developing Bio-based Entities, our Founder & CEO Prof. Dr. Chee-Onn Leong will highlight how AGTC Genomics has grown into a regional hub for advanced genomics, AI-driven analytics, and reference laboratory for precision medicine.

โœจ Our story reflects Malaysiaโ€™s capability to:

๐Ÿ”น Build world-class genomics infrastructure

๐Ÿ”น Advance cancer and infectious disease diagnostics

๐Ÿ”น Empower healthcare with AI analytics for precision medicine

๐Ÿ”น Support regional R&D and translational innovation

Events like NICE 2025 play a pivotal role in driving Malaysiaโ€™s vision of becoming a global bioeconomy leaderโ€”bringing together government, industry, and academia to overcome challenges and create sustainable impact.

We are proud to represent Malaysiaโ€™s progress in genomics and look forward to collaborating with partners across ASEAN and beyond.

๐ŸŒŸ Redefining Cancer Care with GenomicsAt our recent AGTC Genomics CME with the Oncology Department of Pusat Perubatan U...
01/10/2025

๐ŸŒŸ Redefining Cancer Care with Genomics

At our recent AGTC Genomics CME with the Oncology Department of Pusat Perubatan UKM and Pharm-D Health Science we shared how new genomic tools are transforming cancer care:

๐Ÿ’ก Comprehensive Gene Profiling (CPG): Helps doctors find the best treatment by looking at the unique genetic changes in each cancer.

๐Ÿ’ก Liquid Biopsy: A simple blood test that can detect cancer early and monitor response to treatment โ€” without the need for repeated tissue biopsies.

๐Ÿ’ก Minimal Residual Disease (MRD) Testing: Tracks even the smallest traces of cancer that may remain after treatment, helping reduce relapse.

These advances mean more precise, earlier, and less invasive care โ€” giving patients and families hope for better outcomes.

Thank you to HUKM Oncology and Pharm-D for hosting this important session and for championing innovation in cancer treatment. Together, we are making precision oncology a reality.

Address

Kuala Lumpur

Website

Alerts

Be the first to know and let us send you an email when AGTC Genomics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category